Lapatinib-Reference-Cited by-同舟云学术

Lapatinib

Published:2018 Issue: Volume: Page:19-44
ISSN:0080-0015
Container-title:Recent Results in Cancer Research
language:
Short-container-title:

Author:

Voigtlaender Minna,Schneider-Merck Tanja,Trepel Martin

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-91442-8_2

Reference102 articles.

1. Abrahao-Machado LF, Scapulatempo-Neto C (2016) HER2 testing in gastric cancer: an update. World J Gastroenterol 22(19):4619–4625

2. Ansquer Y, Mandelbrot L, Lehy T et al (2005) Expression of BRCA1, HER-1 (EGFR) and HER-2 in sporadic breast cancer and relationships to other clinicopathological prognostic features. Anticancer Res 25(6C):4535–4541

3. Arpino G, Ferrero JM, De la Haba-Rodriguez J (2016) Primary analysis of PERTAIN: a randomized, two-arm, open-label, multicenter phase II trial assessing the efficacy and safety of pertuzumab given in combination with trastuzumab plus an aromatase inhibitor in first-line patients with HER2-positive and hormone receptor-positive metastatic or locally advanced breast cancer. San Antonio Breast Cancer Symposium, San Antonio, USA

4. Bachelot T, Romieu G, Campone M et al (2013) Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study. Lancet Oncol 14(1):64–71

5. Bahreini F, Soltanian AR, Mehdipour P (2015) A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer. Breast Cancer 22(6):615–625

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes-based immunotherapy for cancer: Effective components in the naïve and engineered forms;International Immunopharmacology;2024-09

2. Mechanism-based inactivation of cytochromes P450: implications in drug interactions and pharmacotherapy;Xenobiotica;2024-08-28

3. The Performance and Clinical Applicability of HER2 Digital Image Analysis in Breast Cancer: A Systematic Review;Cancers;2024-08-03

4. HER2-targeted therapies beyond breast cancer — an update;Nature Reviews Clinical Oncology;2024-07-22

5. Ovarian cancer: Diagnosis and treatment strategies (Review);Oncology Letters;2024-07-18